Medicine. The need for a global HIV vaccine enterprise.
Klausner, Richard D;
Fauci, Anthony S;
Corey, Lawrence;
Nabel, Gary J;
Gayle, Helene;
Berkley, Seth;
Haynes, Barton F;
Baltimore, David;
Collins, Chris;
Douglas, R Gordon;
+14 more...Esparza, Jose;
Francis, Donald P;
Ganguly, NK;
Gerberding, Julie Louise;
Johnston, Margaret I;
Kazatchkine, Michel D;
McMichael, Andrew J;
Makgoba, Malegapuru W;
Pantaleo, Giuseppe;
Piot, Peter;
Shao, Yiming;
Tramont, Edmund;
Varmus, Harold;
Wasserheit, Judith N;
(2003)
Medicine. The need for a global HIV vaccine enterprise.
Science (New York, NY), 300 (5628).
pp. 2036-2039.
ISSN 0036-8075
DOI: https://doi.org/10.1126/science.1086916
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
A new collaborative model of research is needed to increase resources, to prioritize the R (ii) to increase the pace, reduce the overlap, and more systematically explore the elements of and delivery systems for vaccines; (iii) to use common standards for the prompt comparative testing of vaccine candidates; (iv) to expand resources for manufacturing vaccine candidates to speed their use in human trials; and (v) to increase the capacity for international clinical trials and to focus this effort toward quickly measuring the effectiveness of vaccine protection as prototype vaccine candidates are identified.
